AI/ML Innovations (HAM:42FB) ROE % Adjusted to Book Value: -30.10% (As of Jan. 2026)


What is AI/ML Innovations ROE % Adjusted to Book Value?

AI/ML Innovations HAM:42FB ROE % Adjusted to Book Value is -30.10% as of Jan. 2026. The stock has 4 warning signs investors should review.

AI/ML Innovations's ROE % for the quarter that ended in Jan. 2026 was -656.13%. AI/ML Innovations's PB Ratio for the quarter that ended in Jan. 2026 was 21.80. AI/ML Innovations's ROE % Adjusted to Book Value for the quarter that ended in Jan. 2026 was -30.10%.

AI/ML Innovations ROE % Adjusted to Book Value Related Terms

AI/ML Innovations ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for AI/ML Innovations's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AI/ML Innovations ROE % Adjusted to Book Value Chart

AI/ML Innovations Annual Data
Trend Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24 Apr25
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

AI/ML Innovations Quarterly Data
Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 -30.10

HAM:42FB vs VEEV, BTSG, TEM: ROE % Adjusted to Book Value Comparison

For the Health Information Services subindustry, AI/ML Innovations's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

AI/ML Innovations ROE % Adjusted to Book Value vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, AI/ML Innovations's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where AI/ML Innovations's ROE % Adjusted to Book Value falls into.


AI/ML Innovations ROE % Adjusted to Book Value Calculation

AI/ML Innovations's ROE % Adjusted to Book Value for the fiscal year that ended in Apr. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-684.78% / N/A
=N/A

AI/ML Innovations's ROE % Adjusted to Book Value for the quarter that ended in Jan. 2026 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-656.13% / 21.80
=-30.10%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of -30.10% mean?
AI/ML Innovations (HAM:42FB) has a ROE % Adjusted to Book Value of -30.10% as of Jan. 2026. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on AI/ML Innovations and its competitors.
Is AI/ML Innovations' ROE % Adjusted to Book Value too high?
AI/ML Innovations' current ROE % Adjusted to Book Value is -30.10%.
How does AI/ML Innovations' ROE % Adjusted to Book Value compare to VEEV and BTSG?
AI/ML Innovations' ROE % Adjusted to Book Value of -30.10% can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Healthcare Providers & Services company?
A good ROE % Adjusted to Book Value depends on the Healthcare Providers & Services industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on AI/ML Innovations and its competitors. AI/ML Innovations's current ROE % Adjusted to Book Value is -30.10%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AI/ML Innovations stock overvalued right now?
AI/ML Innovations (HAM:42FB) has a current ROE % Adjusted to Book Value of -30.10%. The current ROE % Adjusted to Book Value is -30.10%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For AI/ML Innovations (HAM:42FB), the current ROE % Adjusted to Book Value is -30.10% as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

AI/ML Innovations Business Description

Address 645 Fort Street, Suite 203, Victoria, BC, CAN, V8W 1G2
AI/ML Innovations Inc is a holding company. The company along with its subsidiaries is engaged in the research and development of health and wearable technologies, and the sale of licenses and consulting services related to those technologies.